Eli Lilly Licenses ADDF Speech Dataset for Alzheimer’s Research | EconoTimes

Eli Lilly Licenses ADDF Speech Dataset for Alzheimer’s Research | EconoTimes

Lilly’s licensing of the SpeechDx dataset highlights a significant shift toward utilizing accessible, large-scale speech data for Alzheimer’s research. This partnership demonstrates how private industry can leverage specialized, curated public data resources to accelerate discovery without the burden of initial data collection. The initiative underscores the critical value of standardized, multimodal datasets that link voice samples with detailed clinical records. By providing encrypted, pseudonymized access in a controlled environment, the dataset addresses both scientific need and privacy concerns, setting a precedent for secure open data collaboration in health research. This development is highly relevant to the open data community as it proves the viability of shared infrastructure for complex medical studies. It encourages broader adoption of similar models where foundational data assets are made available to multiple researchers, fostering innovation while maintaining rigorous ethical and security standards.

Related news

• Scraped adult Open3DLabs data won't be used in Roblox AI training
• Question 1: Mass. initiative would put governor and lawmakers under state public records law
• Leading Market Sentiment Provider Permutable Launches Data Catalogue for Macroeconomic, Commodity and Geopolitical Research
• Taylor Wimpey lobbied Somerset Council for three years over M5 'garden village'
• Dickson urges INEC to probe alleged AI-generated voter photos